The tumour-associated antigen CA125 provides an adequate tumour marker when measured in the serum of women with advanced adenocarcinoma of the ovary, having a sensitivity of around 850/0. The specificity of the test is in excess of 990/0 in healthy control subjects.' Serial CA125 concentrations are often used to assess the effect of therapy in patients with such tumours. There is increasing evidence that a rise in CA125 levels may be due not only to progressive tumour growth but also as a result of interference with mesothelial cells from non-malignant stimuli.? In patients with ovarian adenocarcinoma we have often seen a small, but significant, transient rise in CA125 concentration following abdominopelvic surgery. This rise, occurring within the first few days after surgery, seems to be unrelated to tumour progression and appears to occur as a result of disturbance to the peritoneum itself. Such post-operative rises may clearly interfere with the clinical usefulness of the assay.
We have investigated this problem by measuring the serum levels of this marker in a series of women undergoing primary cyto-reductive surgery for epithelial ovarian adenocarcinoma. In the six patients studied a laparotomy and tumour debulking was performed. In two of these patients surgery involved extensive retro-peritoneal dissection.
CA125 concentrations were assayed using the immunoradiometric assay (IRMA) from CIS (UK) Ltd (High Wycombe, UK). Serum CA125 was measured at the commencement of surgery, daily in the immediate post-operative period and weekly following discharge from hospital. In each case a rise in CA125 was observed in the early post-operative period and reached a peak within 48 h following surgery before falling again. A Correspondence: Dr J E Roulston. 402 summary of the results are shown in Table 1 . The mean extent of the rise in CA125 value above the pre-operative level was 21 . 6% (SEM 2· 25) and appeared to be independent of the initial preoperative level.
Our results show that the serum CA125 level does rise within the first 48 h following abdominopelvic surgery. It is important to emphasize that the data presented here are from six consecutive patients undergoing surgery and the only selection criterion was the disease itself, namely that all the patients had ovarian carcinoma. Although the increase is small it is reproducible and as a result CA125 levels are of limited value in the immediate post-operative period.
Similar observations have been reported elsewhere. One study has shown a rise in the circulating levels of CA125 following abdominal surgery, but their series of patients comprised a miscellaneous group who had normal preoperative CA125 levels.? Others have demonstrated elevated levels of CA125 in the peritoneal lavage fluid during abdominopelvic surgery but failed to demonstrate a rise in value in the serum level of the marker. 4 More recently, a rise in post-operative CAl25 levels was reported in the serum of a group of patients undergoing a variety of abdominal surgical procedures including second-look laparotomy for ovarian carcinoma, radical hysterectomy for cervical carcinoma and aortic surgery for atherosclerotic disease.' These authors found that the highest levels were reached in the second week following surgery rather than within 48 h as in our patients. The reason for this difference is unclear. One explanation may be related to the fact that in this latter study all the patients had normal CAl25 levelsat the time of surgery. Falling concentrations of CAl25 following tumour removal in our study may have masked the full extent of the postoperative rise in marker concentration. All our patients had both an elevated CA125 at the time of surgery and also active intraperitoneal disease. If, as has been suggested, reactive mesothelial cells express CAl25 and abdominal surgery induces shedding into the peritoneal cavity and then into the peripheral circulation, it is perhaps not surprising that an already reactive peritoneum sheds CAl25 more rapidly and as a result produces a more rapid rise in levels. It is well documented that conditions which irritate or damage the peritoneum such as peritonitis and pelvic inflammatory disease cause an elevation in the circulating levels of CA125. 6 Bearing this in mind it is perhaps not surprising to see a rise in CAl25 as a result of abdominopelvic surgery since this is after all merely a rather specialized form of peritoneal insult.
In two of our patients with localized disease the ovarian pedicles containing the ovarian vessels were clamped immediately the abdomen was opened, thereby minimizing any effect on the The effect of surgery on CA125 403
shedding of CAl25 consequent upon tumour handling. We therefore conclude that the increase in circulating CAl25 values we have observed is principally of extra-tumoral origin and occurs as a result of trauma to the peritoneum during the course of the operative procedure. Assays and calculations based on apparent half-lives calculated from levelsin the early post-operative period are likely to be in error and could lead to misinterpretation of chemotherapeutic effects if drugs are introduced early after surgery.
